It looks like your browser is outdated. For the best experience, please consider updating to the latest version or switching to another browser (Firefox, Chrome, Safari).

This page is not supported in mobiles. Please view it in the desktop version.

BioPharma Solutions BioPharma Solutions
Sterile Contract Manufacturing



In this section, you can view informative webinars about the latest in parenteral techniques and industry trends from Baxter experts.


Building the Future – Using Simulation Effectively
Replay on Demand

This webinar/case study provides an in-depth look at Baxter BioPharma Solutions’ latest expansion at their cytotoxic manufacturing facility in Halle, Germany, providing insight on the following:

  • Handling of complex expansion projects
  • Elements of process design
  • Application of different simulation and visualization tools
  • Innovations for manufacturing of parenterals
  • Effective team building

Delivering Biologics With a Difference
Replay on Demand

Baxter’s proprietary GALAXY technology is currently the only manufacturer-prepared commercial scale aseptic filling process for premixed drugs in flexible IV bags, delivering the first-ever biologic in an intravenous bag. This webinar will explore the advantages, challenges, case studies and science behind delivering biologics with a difference.

    Key learning objectives:
  • Learn about the possibility of delivering intravenous-dosed biologics in an aseptically-filled intravenous bag
  • Increase your understanding of the business drivers and potential value added with this strategy
  • Increase awareness for the timeline required and ideal lifecycle timing to implement

New Guidelines for Stabilization of Proteins by Freeze Drying: Formulation and Process Heresy
Replay On Demand

Over the years a number of informal guidelines or “rules” for the formulation and processing of proteins for freeze-drying have been developed. However, in recent years it has become obvious that some of these rules need modification. In this presentation, Dr. Michael J. Pikal, Ph.D, suggests “revisions” to these historical rules.

Biosimilar Regulations and CMOs
Replay On Demand

In this webinar, moderated by Fierce Biotech’s editor, Kelly Davis, Regulatory Affairs Associate Director at Baxter BioPharma Solutions, will present in a discussion of recently-passed Biosimilar legislation. The purpose of the webinar is to help CMOs understand the significance of the legislation to their businesses and how the new legislation may help, or hurt, contract manufacturing for biologics.

Enhanced Delivery Options for Injectables

In this webinar, Baxter’s Kristie Zinselmeier and BD’s Brian Lynch present the challenges and opportunities of injectable administration, including global market trends, enhanced delivery case studies, market research, and lifecycle management through collaboration

Shoot for Share: From Vial to Prefilled Syringe

This webinar features Baxter’s Raul Soikes, Sr. Director, Program Management, and provides insight on:

  • Value proposition of moving to a prefilled syringe
  • Regulatory planning to enable the move
  • Process to move from vial (liquid or lyophilized) to syringe
  • Qualifications of partners

*To view the webinars as WebEx files, download the free plugin here:

events events


Talk to us at these events